Medicines Manufacturing Innovation Centre
Redefining the future of pharmaceutical production with cutting-edge digital technology, collaborative expertise, and more sustainable manufacturing practices.
Accelerating drug development and manufacturing
Located in Renfrewshire, Scotland, the Medicines Manufacturing Innovation Centre is a collaboration between CPI, University of Strathclyde, UK Research & Innovation, Scottish Enterprise and founding industry partners, AstraZeneca, and GSK.
The Centre fosters collaboration between industry, academia, healthcare providers and regulators to revolutionise how life-changing medicines are developed.
By tapping into the centre’s state-of-the-art facilities promoting knowledge exchange and synergy, innovators can overcome technical and regulatory challenges, reduce time to market, gain a competitive edge, and meet the demand for more eco-friendly manufacturing practices.
Our approach to innovation
Ageing populations, resource constraints, and high drug development costs coupled with the increasing need for cost-effective medication is holding pharma companies back from adopting emergent technologies.
The aim of the centre is to accelerate the development of a new generation of manufacturing processes – from formulation development to advanced analytical tools – and to help companies integrate these into their existing models.
Tackling today’s problems for tomorrow’s healthcare
We use the Grand Challenge model to address complex industrial hurdles currently limiting pharmaceutical manufacturing. By initially focusing our attention on four areas, we are creating partnerships of innovation to build healthcare systems of the future.
![Tablets Tablets](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/tablets.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1559214811&s=cd250451f7b940242b95dd0ba929da3a 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/tablets.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1559214811&s=65ba24ac142cef078105f350dd1d3f06 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/tablets.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1559214811&s=9a5c7212ce8648d37fe4a04f20c8d056 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/tablets.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1559214811&s=80b2bb664fade43d4d6f298748104302 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/tablets.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1559214811&s=efbd7c8a599cf0d93c691e3309e1e0f1 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/tablets.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1559214811&s=f14cd10c1ff0ad478862e11926d2162e 960w)
Switching to continuous manufacturing
In Grand Challenge 1, we’re transforming oral solid dose formulation, development, and manufacture by developing a novel, digitally twinned continuous direct compression (CDC) platform. It will support the industry to shift to more rapid response continuous and minibatch manufacturing approach that’s cheaper and more energy efficient.
![Tablet in a medical setting Tablet in a medical setting](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-ipad.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1559211883&s=53e4b6a24d0c5fd964f21b87f00998cc 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-ipad.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1559211883&s=7d82d46a4ce5523c36ae20e1d1b74fa9 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-ipad.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1559211883&s=99df71596da8536ad7185df513e84ef4 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-ipad.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1559211883&s=004ec84ff975292c47c446d322785ead 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-ipad.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1559211883&s=4a52aaeac10145715c595496acf09aee 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-ipad.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1559211883&s=aa1905dedd62564831e5d07e0392891e 960w)
Transforming clinical trial supply chains
In Grand Challenge 2, we’re focusing on delivering automated just-in-time clinical supply to increase speed, flexibility, and efficiency in clinical trial drugs manufacture. This work will overcome long lead times for supplying medicines, avoid wastage, and make it easier to respond to patient demand.
![Molecules Molecules](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Oligonucleotides.png?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1692707980&s=1b620fd5e0eca7a3bed9d354a7200aa1 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Oligonucleotides.png?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1692707980&s=ff7367840d0e500d4aa9034c41f58cff 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Oligonucleotides.png?w=2240&h=1260&q=45&fm=jpg&fit=crop&dm=1692707980&s=af120d9ef77578b1736daf77bcef1304 2240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Oligonucleotides.png?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1692707980&s=1ac0e373e20ec4f249aa213b2884704a 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Oligonucleotides.png?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1692707980&s=27461a2490a8e57b810faaccb890e1c8 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Oligonucleotides.png?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1692707980&s=20e9c486d8f7a4a63e0845434c653c3c 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Oligonucleotides.png?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1692707980&s=503d49fad6fcf3492b19f2a059a578e7 960w)
Producing oligonucleotides sustainably
In Grand Challenge 3, we’re developing revolutionary manufacturing processes for more sustainable, large-scale production of oligonucleotides. This next-generation therapeutic has the potential to revolutionise our approach to disease treatment and find therapies for currently‘undruggable’ diseases.
![Pharmaceutical manufacturing equipment Pharmaceutical manufacturing equipment](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/digital-industrial-manufacturing.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1559223438&s=4acb696a98577a333f90428d46eadfdc 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/digital-industrial-manufacturing.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1559223438&s=def600e991211f0e84da75a28a494454 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/digital-industrial-manufacturing.jpg?w=2240&h=1260&q=45&fm=jpg&fit=crop&dm=1559223438&s=d15d5c9fdae05f39a903ece3e2060038 2240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/digital-industrial-manufacturing.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1559223438&s=b9d67db4182e24a0cf418e3bcfa1cf55 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/digital-industrial-manufacturing.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1559223438&s=d0dbe3da9232a0fdffea51befc83155a 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/digital-industrial-manufacturing.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1559223438&s=bf89013c7913d9cb81ffb4255025efb1 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/digital-industrial-manufacturing.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1559223438&s=f66f653d4f2fb297956a9ff5c70dbbe6 960w)
Driving digital manufacturing
In the Digital Membership we’re uniting our Pharma, Technology and Delivery partners to standardise and, through effective use of data and systems connectivity, expedite uptake of smart, connected technologies such as machine learning, AI, and robotics. This is an open community which you could join. Working towards pharma industry 4.0 we will improve patient outcomes, increase sustainability and flexibility, and reduce costs.
Partnering with us
The Medicines Manufacturing Innovation Centre empowers companies of all sizes to enhance their capabilities, drive innovation, and establish themselves as key players in the pharmaceutical industry.
Together, we can pave the way for ground-breaking therapies and improve patient access to high-quality medicines.
We are looking for more partners to join and shape our Grand Challenges, get in touch.
For more information
![Neil Sheddan Neil Sheddan](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/neil-sheddan.jpg?w=480&h=480&auto=compress%2Cformat&fit=crop&dm=1610377813&s=5ec42a9203b221aacc572048a7815985)
Neil Sheddan
Business Development Director
Latest updates and news
Insights and articles
Partners and Funders
![ukri ukri](https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/ukri.jpg?w=400&h=225&q=100&fm=png&fit=crop&dm=1707410818&s=433dfaeb19c7816a259f215ab2947262 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/ukri.jpg?w=800&h=450&q=75&fm=png&fit=crop&dm=1707410818&s=19ed2d94d96f2fe6a4c043e7a3757e90 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/ukri.jpg?w=240&h=135&q=75&fm=png&fit=crop&dm=1707410818&s=a13f3e668d664f82140780a06e4ab5d0 240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/ukri.jpg?w=480&h=270&q=75&fm=png&fit=crop&dm=1707410818&s=ea2bd4aff4cb87ebf4962ee95c1a10f8 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/ukri.jpg?w=120&h=67&q=100&fm=png&fit=crop&dm=1707410818&s=bead72a75b784039198bf7e65f93bfd9 120w)
![mmic-partner-scottish-uni-strath mmic-partner-scottish-uni-strath](https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-uni-strath.png?w=400&h=225&q=100&fm=png&fit=crop&dm=1645703821&s=a724ce1166ee4a2a3b5852b0b803d27d 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-uni-strath.png?w=800&h=450&q=75&fm=png&fit=crop&dm=1645703821&s=00bbddcfa62fa199313a456b154b10a0 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-uni-strath.png?w=240&h=135&q=75&fm=png&fit=crop&dm=1645703821&s=cfcb7d67f6a9aacf64c6f5b71ca80e67 240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-uni-strath.png?w=480&h=270&q=75&fm=png&fit=crop&dm=1645703821&s=1a9ac6da273884ac1738f252c5accc86 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-uni-strath.png?w=120&h=67&q=100&fm=png&fit=crop&dm=1645703821&s=16363441d51b0b08ece875636eff19b3 120w)
![mmic-partner-scottish-scottish-gov mmic-partner-scottish-scottish-gov](https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-scottish-gov.png?w=400&h=225&q=100&fm=png&fit=crop&dm=1645703925&s=30aac7a2b6df786a8b3359ffe1f2e8d9 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-scottish-gov.png?w=800&h=450&q=75&fm=png&fit=crop&dm=1645703925&s=9e93a13c44aaaa276b583d6c38f02873 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-scottish-gov.png?w=240&h=135&q=75&fm=png&fit=crop&dm=1645703925&s=25856b2e834a54fdc089cd3501336923 240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-scottish-gov.png?w=480&h=270&q=75&fm=png&fit=crop&dm=1645703925&s=666c25d7f9625c5d2948a4f241f7a6f2 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-scottish-gov.png?w=120&h=67&q=100&fm=png&fit=crop&dm=1645703925&s=cbc75421a78d4b7315b18dc76da8f925 120w)
![mmic-partner-scottish-cpi mmic-partner-scottish-cpi](https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-cpi.png?w=400&h=225&q=100&fm=png&fit=crop&dm=1645704076&s=1a72521ede5786323adcd0a48f2abed1 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-cpi.png?w=800&h=450&q=75&fm=png&fit=crop&dm=1645704076&s=b6394afd9433a2719751ed355a0c9ea3 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-cpi.png?w=240&h=135&q=75&fm=png&fit=crop&dm=1645704076&s=9d1161755c6378c92c8d8bfd6399f1f2 240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-cpi.png?w=480&h=270&q=75&fm=png&fit=crop&dm=1645704076&s=0eb5286270a64296d9d194e92919b9e0 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/mmic-partner-scottish-cpi.png?w=120&h=67&q=100&fm=png&fit=crop&dm=1645704076&s=1c3aae894e2669fb2cbdd495d2daec68 120w)
![AZ AZ](https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/AZ.png?w=400&h=225&q=100&fm=png&fit=crop&dm=1707218838&s=fee39d10f19f59cef0f89748d01eac33 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/AZ.png?w=800&h=450&q=75&fm=png&fit=crop&dm=1707218838&s=07534ab5df6e2ecfd570903b73c1c64a 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/AZ.png?w=240&h=135&q=75&fm=png&fit=crop&dm=1707218838&s=124d5220ec7b472e610ec50e805f6c52 240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/AZ.png?w=480&h=270&q=75&fm=png&fit=crop&dm=1707218838&s=097161f38a183f519f4e19b4b6aa30e1 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/AZ.png?w=120&h=67&q=100&fm=png&fit=crop&dm=1707218838&s=d38d57b592e75ab6ded59243df0d50d8 120w)
![SE SE](https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/SE.png?w=400&h=225&q=100&fm=png&fit=crop&dm=1707218903&s=1ed86da1b82d1a524d1a1b04e79531d2 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/SE.png?w=800&h=450&q=75&fm=png&fit=crop&dm=1707218903&s=48f8eaff841835a240d54da859ab63e7 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/SE.png?w=240&h=135&q=75&fm=png&fit=crop&dm=1707218903&s=731ab183c4f980046ec29787ae07013f 240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/SE.png?w=480&h=270&q=75&fm=png&fit=crop&dm=1707218903&s=44612f92c7c172e57253e6442005f3c3 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/SE.png?w=120&h=67&q=100&fm=png&fit=crop&dm=1707218903&s=a7b0f02b5205f8fbd6f4c38a5c23cf44 120w)
![GSK GSK](https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/GSK.png?w=400&h=225&q=100&fm=png&fit=crop&dm=1707218932&s=7406d384e530937b23bce059d8378eea 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/GSK.png?w=800&h=450&q=75&fm=png&fit=crop&dm=1707218932&s=3af30042796fafc0f4e6ee03e771c4e7 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/GSK.png?w=240&h=135&q=75&fm=png&fit=crop&dm=1707218932&s=fbb56513fa8f77dfc191279b936d0fba 240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/GSK.png?w=480&h=270&q=75&fm=png&fit=crop&dm=1707218932&s=c0435a820788bf186722178d184d3a38 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/logos/GSK.png?w=120&h=67&q=100&fm=png&fit=crop&dm=1707218932&s=5a34f19e76b54153f0f832531a748a04 120w)
Related Technologies
Let’s innovate together
To find out more about how we can work together, please enter your details below.